Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Glucagonlike peptide 1 (GLP-1) is a physiological regulator of appetite, and long-acting GLP-1 receptor (GLP-1R) agonists lower food intake and body weight in both human and animal studies. The effects are mediated through brain GLP-1Rs, and several brain nuclei expressing the GLP-1R may be involved. To date, the mapping of the complete location of GLP-1R protein in the brain has been challenged by lack of good antibodies and the discrepancy between mRNA and protein, especially relevant in neuronal axonal processes. Here, we present a specific monoclonal GLP-1R antibody for immunohistochemistry with murine tissue and show detailed distribution of GLP-1R expression, as well as mapping of GLP-1R mRNA by nonradioactive in situ hybridization. Semiautomated image analysis was performed to map the GLP-1R distribution to atlas plates from the Allen Institute for Brain Science. The GLP-1R was abundantly expressed in numerous regions, including the septal nucleus, hypothalamus, and brain stem. GLP-1R protein expression was also observed on neuronal projections in brain regions devoid of any mRNA that has not been observed in earlier reports. Taken together, these findings provide knowledge on GLP-1R expression in neuronal cell bodies and neuronal projections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We also detected the expression of GLP-1Rs in the DMH of GLP-1R–tdTomato reporter mice (Fig. 1H) (19, 20).”
From GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans (2024) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572 · cited 2×
“The GLP-1R distribution was mapped by image segmentation following semiautomatic registration of the scanned histological slides to digital atlas plates from the Allen Institute for Brain Science (AIBS) mouse brain reference model (16, 17).”
MethodElastix: a toolbox for intensity-based medical image registration
Klein, S., Staring, M., Murphy, K., Viergever, M. A., & Pluim, J. (2010) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2009.2035616 · Cited by 4,311 · cited 1×
“All registrations were computed using Elastix (21).”
On the Dependency of Cellular Protein Levels on mRNA Abundance
Liu, Y., Beyer, A., & Aebersold, R. (2016) · Cell · doi:10.1016/j.cell.2016.03.014 · Cited by 3,221
A mesoscale connectome of the mouse brain
Oh, S. W., Harris, J. A., Ng, L., Winslow, B., Cain, N., Mihalas, S., Wang, Q., Lau, C., Kuan, L., Henry, A. M., et al. (2014) · Nature · doi:10.1038/nature13186 · Cited by 2,612 · cited 2×
“The GLP-1R distribution was mapped by image segmentation following semiautomatic registration of the scanned histological slides to digital atlas plates from the Allen Institute for Brain Science (AIBS) mouse brain reference model (16, 17).”
Method(2012) · doi:10.1016/j.jmoldx.2011.08.002 · Cited by 2,567 · cited 1×
“ISH was performed using the RNAscope platform (19, 20) on neighboring sections to the sections used for whole brain IHC mapping.”
MethodThe three-dimensional organization of the hippocampal formation: A review of anatomical data
Amaral, D. G., & Witter, M. P. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90424-7 · Cited by 2,180
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 1×
“have a role in central regulating of feeding in rat and human GLP-1–activated brain areas known to regulate food intake (1).”
BackgroundADULT NEUROGENESIS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
Ming, G.-L., & Song, H. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.051804.101459 · Cited by 1,839
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297 · cited 4×
“668 Jensen et al Glucagonlike Peptide 1 Receptor Characterization Endocrinology, February 2018, 159(2):665–675”
BackgroundInfluential
Research works printed but not linked: 1
- McClean P.L, Parthsarathy V, Faivre E, Hölscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. Journal of Neuroscience, 2011;31(17):6587-6594. doi:10.1523/JNEUROSCI.0529-11.2011. · DOI · Paper page
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“In mice, GLP-1R-positive cells were identified in several regions of the telencephalon (olfactory bulb, amygdala, preoptic area, nucleus accumbens, septum), diencephalon (hypothalamic arcuate nucleus, paraventricular nucleus, dorsomedial nucleus, the lateral hypothalamic nucleus and the supraoptic nucleus) and regions…”
BackgroundThe Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Self-citationSemaglutide lowers body weight in rodents via distributed neural pathways.
Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133429 · Cited by 717
“Furthermore, this engagement is likely to be indirect because expression of GLP-1Rs on NTS GLP-1–producing cells has not been documented (82).”
BackgroundInfluentialSelf-citationWong, C. K., McLean, B. A., Baggio, L. L., Koehler, J. A., Hammoud, R., Rittig, N., Yabut, J. M., Seeley, R. J., Brown, T. J., & Drucker, D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.11.009 · Cited by 304
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
McLean, B. A., Wong, C. K., Campbell, J. E., Hodson, D. J., Trapp, S., & Drucker, D. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa032 · Cited by 289
Klausen, M. K., Jensen, M. E., Møller, M., Le Dous, N., Jensen, A.-M. Ø., Zeeman, V. A., Johannsen, C.-F., Lee, A., Thomsen, G. K., Macoveanu, J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159863 · Cited by 262
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
“expressed in brain regions believed to be involved in reward and addiction (Cork et al., 2015; Han et al., 1986; Jensen et al., 2018; Merchenthaler et al., 1999; Rinaman, 2010; Vrang & Grove, 2011).”
BackgroundEnterochromaffin 5-HT cells – A major target for GLP-1 and gut microbial metabolites
Lund, M. L., Egerod, K. L., Engelstoft, M. S., Dmytriyeva, O., Theodorsson, E., Patel, B. A., & Schwartz, T. W. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.004 · Cited by 254
“Importantly, expression of the GLP-1 receptor could be demonstrated also at the protein level through staining of 5-HT cells with a selective monoclonal receptor antibody (Figure 6C) [47].”
BackgroundMethodIntegrative neurocircuits that control metabolism and food intake
Brüning, J. C., & Fenselau, H. (2023) · Science · doi:10.1126/science.abl7398 · Cited by 214
“Studies in mice, rats, and nonhuman primates have revealed that GLP-1 – responsive cells are distributed throughout the NTS/AP ( 118 , 144 – 146 ) and that the activity of these cells contributes to the observed feeding suppression and body weight loss upon administration of GLP-1 analogs ( 118 ).”
Chuong, V., Farokhnia, M., Khom, S., Pince, C. L., Elvig, S. K., Vlkolinsky, R., Marchette, R. C. N., Koob, G. F., Roberto, M., Vendruscolo, L. F., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.170671 · Cited by 214
Salameh, T. S., Rhea, E. M., Talbot, K., & Banks, W. A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114187 · Cited by 188
“Hervé F, Ghinea N, Scherrmann JM, CNS delivery via adsorptive transcytosis, Aaps j 10(3) (2008) 455–72.”
BackgroundResultInfluentialA genetic map of the mouse dorsal vagal complex and its role in obesity
Ludwig, M. Q., Cheng, W., Gordian, D., Lee, J., Paulsen, S. J., Hansen, S. N., Egerod, K. L., Barkholt, P., Rhodes, C. J., Secher, A., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00363-1 · Cited by 186
Self-citationDissociable hindbrain GLP1R circuits for satiety and aversion
Huang, K.-P., Acosta, A. A., Ghidewon, M. Y., McKnight, A. D., Almeida, M. S., Nyema, N. T., Hanchak, N. D., Patel, N., Gbenou, Y. S. K., Adriaenssens, A. E., et al. (2024) · Nature · doi:10.1038/s41586-024-07685-6 · Cited by 166
“In the DVC, the AP and NTS both express GLP1R 11,12 (Fig.”
Trapp, S., & Brierley, D. I. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15638 · Cited by 154
GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans
Kim, K. S., Park, J. S., Hwang, E., Park, M. J., Shin, H. Y., Lee, Y. H., Kim, K. M., Gautron, L., Godschall, E., Portillo, B., et al. (2024) · Science · doi:10.1126/science.adj2537 · Cited by 148
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146
“Consistent with the ability of GLP-1R agonists to decrease homeostatic and hedonic food intake (29, 29), expression GLP1R is found in the rodent hypothalamus (ARC, VMH, DMH, PVH, LH), hindbrain (AP, NTS, ventrolateral medulla) and telencephalon (amygdala, olfactory bulb, preoptic area, nucleus accumbens) (45, 46).”
BackgroundFull-length human GLP-1 receptor structure without orthosteric ligands
Wu, F., Yang, L., Hang, K., Laursen, M., Wu, L., Han, G. W., Ren, Q., Roed, N. K., Lin, G., Hanson, M. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14934-5 · Cited by 139
Zhao, L., Li, Z., Vong, J. S. L., Chen, X., Lai, H.-M., Yan, L. Y. C., Huang, J., Sy, S. K. H., Tian, X., Huang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18249-3 · Cited by 126
Marzook, A., Tomas, A., & Jones, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.678055 · Cited by 121
“Comparisons of mRNA versus protein distribution typically deliver congruent results, with exceptions including GLP-1R protein detected on neuronal projections distant from the their respective Glp1r transcript-containing cell bodies (14), and instances where low abundance Glp1r transcripts, e.”
ResultNutrient-Induced Cellular Mechanisms of Gut Hormone Secretion
Lu, V. B., Gribble, F. M., & Reimann, F. (2021) · Nutrients · doi:10.3390/nu13030883 · Cited by 117
Enteroendocrine cell regulation of the gut-brain axis
Barton, J. R., Londregan, A., Alexander, T. D., Entezari, A. A., Covarrubias, M., & Waldman, S. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1272955 · Cited by 102
Bruns VI, N., Tressler, E. H., Vendruscolo, L. F., Leggio, L., & Farokhnia, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107312 · Cited by 89
Dong, M., Wen, S., & Zhou, L. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s375559 · Cited by 90
Actions of glucagon‐like peptide‐1 receptor ligands in the gut
Holst, J. J., Andersen, D. B., & Grunddal, K. V. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15611 · Cited by 73
Farkas, E., Szilvásy-Szabó, A., Ruska, Y., Sinkó, R., Rasch, M. G., Egebjerg, T., Pyke, C., Gereben, B., Knudsen, L. B., & Fekete, C. (2021) · Brain Structure and Function · doi:10.1007/s00429-020-02189-1 · Cited by 73
“Studies using a variety of histology-based methods have convincingly demonstrated the widespread distribution of GLP-1R in the central nervous system (CNS) (Merchenthaler et al.”
BackgroundSelf-citationCosta, A., Ai, M., Nunn, N., Culotta, I., Hunter, J., Boudjadja, M. B., Valencia-Torres, L., Aviello, G., Hodson, D. J., Snider, B. M., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101407 · Cited by 79
Holst, J. J., Albrechtsen, N. J. W., Rosenkilde, M. M., & Deacon, C. F. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180013 · Cited by 54
Lingvay, I., Hansen, T., Macura, S., Marre, M., Nauck, M. A., de la Rosa, R., Woo, V., Yildirim, E., & Wilding, J. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001706 · Cited by 71
Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis
Luo, P., Lednovich, K., Xu, K., Nnyamah, C., Layden, B. T., & Xu, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.003 · Cited by 65
Guerrero-Hreins, E., Goldstone, A. P., Brown, R. M., & Sumithran, P. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110303 · Cited by 62
Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor
Mishra, I., Xie, W. R., Bournat, J. C., He, Y., Wang, C., Silva, E. S., Liu, H., Ku, Z., Chen, Y., Erokwu, B. O., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.012 · Cited by 67
Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity
Knudsen, L. B. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00048 · Cited by 56
Self-citationGLP-1 Receptor Agonists: Promising Therapeutic Targets for Alcohol Use Disorder
Jerlhag, E. (2025) · Endocrinology · doi:10.1210/endocr/bqaf028 · Cited by 64
Cao, B., Zhang, Y., Chen, J., Wu, P., Dong, Y., & Wang, Y. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00879-1 · Cited by 63
“Studies have found that GLP-1R is expressed in the central nervous system, including the cerebral cortex, hypothalamus, hippocampus, thalamus, substantia nigra, and cerebellum (Cork et al. 2015; Graham et al. 2020; Jensen et al. 2018).”
BackgroundGerstenberg, M. K., Salinas, C. B. G., Rehfeld, J. F., Secher, A., Raun, K., & Wulff, B. S. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.11.004 · Cited by 56
“For details of brain atlas and image registration, see reference (Jensen et al., 2018).”
BackgroundSelf-citationChen, X.-Y., Chen, L., Yang, W., & Xie, A.-M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.793004 · Cited by 52
Pang, J., Feng, J. N., Ling, W., & Jin, T. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.003 · Cited by 52
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
Quarta, C., Stemmer, K., Novikoff, A., Yang, B. S., Klingelhuber, F., Harger, A., Bakhti, M., Bastidas-Ponce, A., Baugé, E., Campbell, J. E., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00617-6 · Cited by 52
Peptides in the regulation of glucagon secretion
Andersen, D. B., & Holst, J. J. (2022) · Peptides · doi:10.1016/j.peptides.2021.170683 · Cited by 43
“have been generated, providing a clearer picture [181].”
Holt, M. K., & Rinaman, L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15576 · Cited by 57
Péterfi, Z., Szilvásy-Szabó, A., Farkas, E., Ruska, Y., Pyke, C., Knudsen, L. B., & Fekete, C. (2021) · Neuroendocrinology · doi:10.1159/000512806 · Cited by 42
Self-citationSmith, C., Patterson-Cross, R., Woodward, O., Lewis, J., Chiarugi, D., Merkle, F., Gribble, F., Reimann, F., & Adriaenssens, A. (2022) · Appetite · doi:10.1016/j.appet.2022.106022 · Cited by 47
Obesity pharmacotherapy: incretin action in the central nervous system
Boer, G. A., Hay, D. L., & Tups, A. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.11.001 · Cited by 52
Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex
Ludwig, M. Q., Todorov, P. V., Egerod, K. L., Olson, D. P., & Pers, T. H. (2021) · Diabetes · doi:10.2337/dbi21-0003 · Cited by 38
GLP-1 and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential
Moaket, O. S., Obaid, S. E., Obaid, F. E., Shakeeb, Y. A., Elsharief, S. M., Tania, A., Darwish, R., Butler, A. E., & Moin, A. S. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110743 · Cited by 46
Liu, C. M., Killion, E. A., Hammoud, R., Lu, S.-C., Komorowski, R., Liu, T., Kanke, M., Thomas, V. A., Cook, K. D., Sivits, G. N., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01295-w · Cited by 44
“Interestingly, many of these brain regions do not express Gipr or Glp1r 31,32 , suggesting that these are secondary downstream pathways that are activated indirectly by mGIPR-Ab/P3.”
Hansen, H. H., Pors, S. E., Andersen, M. W., Vyberg, M., Nøhr-Meldgaard, J., Nielsen, M. H., Oró, D., Madsen, M. R., Lewińska, M., Møllerhøj, M. B., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-50328-5 · Cited by 42
Reagents and models for detecting endogenous GLP1R and GIPR
Ast, J., Broichhagen, J., & Hodson, D. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103739 · Cited by 40
A brainstem to hypothalamic arcuate nucleus GABAergic circuit drives feeding
de Morentin, P. B. M., González, J. A., Dowsett, G. K. C., Martynova, Y. V., Yeo, G. S. H., Sylantyev, S., & Heisler, L. K. (2024) · Current Biology · doi:10.1016/j.cub.2024.02.074 · Cited by 39
GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling
Kooij, K. L., Koster, D. I., Eeltink, E., Luijendijk, M. C. M., Drost, L., Ducrocq, F., & Adan, R. A. H. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.103925 · Cited by 39
“Earlier studies suggest semaglutide cannot directly access the midbrain but can assess brain areas such as the NTS, ARC or lateral septum (Gabery et al., 2020; Hansen et al., 2021; Jensen et al., 2018).”
Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes
von Herrath, M., Pagni, P. P., Grove, K., Christoffersson, G., Tang-Christensen, M., Karlsen, A. E., & Petersen, J. S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.004 · Cited by 39
Gupta, T., Kaur, M., Shekhawat, D., Aggarwal, R., Nanda, N., & Sahni, D. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.2554.2 · Cited by 41
Huang, J., Liu, Y., Cheng, L., Li, J., Zhang, T., Zhao, G., & Zhang, H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173581 · Cited by 36
Bakker, W., Imbernón, M., Salinas, C. G., Chao, D. H. M., Hassouna, R., Morel, C., Martin, C., Leger, C., Denis, R., Castel, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111698 · Cited by 38
“C.G.S. and J.H.-S. are no longer affiliated with Novo Nordisk at the time of manuscript submission.”
InfluentialSelf-citationZhou, W., Shao, W., Zhang, Y., Liu, D., Liu, M., & Jin, T. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00292.2020 · Cited by 36
Allingbjerg, M.-L., Hansen, S. N., Secher, A., & Thomsen, M. (2022) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000620 · Cited by 37
Self-citationAst, J., Nasteska, D., Fine, N. H. F., Nieves, D. J., Kőszegi, Z., Lanoiselée, Y., Cuozzo, F., Viloria, K., Bacon, A., Luu, N. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35716-1 · Cited by 36
Citraro, R., Iannone, M., Leo, A., Caro, C. D., Nesci, V., Tallarico, M., Abdalla, K., Palma, E., Arturi, F., Sarro, G. D., et al. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.001 · Cited by 34
Edvardsson, C. E., Cadeddu, D., Ericson, M., Adermark, L., & Jerlhag, E. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105684 · Cited by 33
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
Folli, F. B., Finzi, G., Manfrini, R., Galli, A., Casiraghi, F., Centofanti, L., Berra, C., Fiorina, P., Davalli, A. M., Rosa, S. L., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00236.2023 · Cited by 35
Meca, A.-D., Boboc, I. K. Ş., Mititelu-Tarțău, L., & Bogdán, M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060354 · Cited by 33
Kuthati, Y., Davuluri, V. N. G., & Wong, C. (2025) · Biomolecules · doi:10.3390/biom15050622 · Cited by 32
Skovbjerg, G., Roostalu, U., Salinas, C. G., Skytte, J. L., Perens, J., Clemmensen, C., Elster, L., Frich, C. K., Hansen, H. H., & Hecksher‐Sørensen, J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109637 · Cited by 32
Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder
Klausen, M. K., Knudsen, G. M., Vilsbøll, T., & Fink‐Jensen, A. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70004 · Cited by 35
Histaminergic regulation of food intake
Khouma, A., Moeini, M. M., Plamondon, J., Richard, D., Caron, A., & Michael, N. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1202089 · Cited by 33
Incretin therapy for diabetes mellitus type 2
Holst, J. J. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000516 · Cited by 32
“Although there are clearly GLP-1 receptors in the mentioned circumventricular organs [18], there are many more GLP-1 receptors in the brain, which do not seem to be accessible for peripheral GLP-1 or GP-1RAs [19].”
BackgroundMayer, F., Gunawan, A. L., Tso, P., & Aponte, G. W. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00189.2019 · Cited by 32
Zeng, N., Cutts, E. J., Lopez, C. B., Kaur, S., Duran, M., VIRKUS, S., & Hardaway, J. A. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.724030 · Cited by 27
Balk-Møller, E., Windeløv, J. A., Svendsen, B., Hunt, J., Ghiasi, S. M., Sørensen, C. M., Holst, J. J., & Kissow, H. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz034 · Cited by 22
“The primary antibodies used were GLP-1R ab clone 7F38-s (55,56,57) diluted 1:50 and mannose receptor ab (58) diluted 1:12 000.”
MethodLiu, Q., Garg, P., Hasdemir, B., Wang, L., Tuscano, E., Sever, E. N., Rivera, E. K., Hernandez, A. G. L., Yuan, T. Z., Kwan, E., et al. (2021) · mAbs · doi:10.1080/19420862.2021.1893425 · Cited by 24
Magdy, Y., Kamar, S. A., Habib, M. Z., Rady, H. Y., Rabei, M. R., & Khedr, S. A. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06834-7 · Cited by 25
“In situ hybridization technique and immunohistochemical studies revealed that GLP-1 receptors (GLP-1R) are widely distributed throughout the brain in the cerebral cortex, hypothalamus, hippocampus, thalamus, caudate nucleus, and medulla oblongata (Farr et al. 2016; Jensen et al. 2018 ).”
Psilopanagioti, A., Nikou, S., Logotheti, S., Arbi, M., Chartoumpekis, D. V., & Papadaki, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314899 · Cited by 22
Neuroimaging and neuroendocrine insights into food cravings and appetite interventions in obesity
Huang, J., Wang, C., Zhang, H.-B., Zheng, H., Huang, T., & Di, J. (2023) · Psychoradiology · doi:10.1093/psyrad/kkad023 · Cited by 24
Glial Modulation of Energy Balance: The Dorsal Vagal Complex Is No Exception
Troadec, J., Gaigé, S., Barbot, M., Lebrun, B., Barbouche, R., & Abysique, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020960 · Cited by 24
“Recent studies using IHC with highly selective antibodies provided a complete atlas of GLP-1R in the mouse [93,94] and rat [95] brains.”
BackgroundBrain Imaging of the GLP-1 Receptor in Obesity Using 68Ga-NODAGA-Exendin-4 PET
Deden, L. N., Booij, J., Grandjean, J., Homberg, J. R., Hazebroek, E. J., Gotthardt, M., & Boss, M. (2021) · Brain Sciences · doi:10.3390/brainsci11121647 · Cited by 21
Genetic Variability of Incretin Receptors and Alcohol Dependence: A Pilot Study
Tsermpini, E. E., Goričar, K., Plesničar, B. K., Ilješ, A. P., & Dolžan, V. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.908948 · Cited by 18
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Feng, J. N., & Jin, T. (2024) · Medical Review · doi:10.1515/mr-2024-0018 · Cited by 18
“Certain relatively reliable GLP-1R antibodies (3F52 for humans and 7F38 for mice) have been generated by Knud-sen ’ s team, which can be utilized in the detection of GLP-1R expression by immunohistochemistry (IHC) [85, 86].”
BackgroundNofal, A. E., AboShabaan, H. S., Fadda, W. A., Ereba, R. E., Elsharkawy, S. M., & Hathout, H. M. R. (2024) · Cells · doi:10.3390/cells13090732 · Cited by 17
“Primary antibodies against the glucagon-like peptide-1 receptor (GLP-1R, 1:200, NBP1-97308, Novus Biologicals, USA) and beta-catenin ( β -Cat, BD Biosciences, San Jose, CA) were used as described by Jensen et al. [36] and Zou et al. [37], respectively.”
MethodVastagh, C., Farkas, I., Scott, M. M., & Liposits, Z. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02167-7 · Cited by 17
Le, T. D. V., Liu, D., Besing, G.-L. K., Raghavan, R., Ellis, B. J., Ceddia, R. P., Collins, S., & Ayala, J. E. (2023) · eLife · doi:10.7554/elife.80944 · Cited by 16
“This suggests that Raptor phosphorylation at Ser 791 by PKA contributes to the weight loss effect of GLP-1R agonists but not other G s-targeting pharmacological agents such as setmelanotide.”
BackgroundGABA requires GLP-1R to exert its pancreatic function during STZ challenge
Shao, W., Liu, W., Liang, P., Song, Z., Israel, O., Prud’homme, G. J., Wang, Q., & Jin, T. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0109 · Cited by 15
Reassessment of antibody-based detection of the murine T cell GLP-1 receptor
Wong, C. K., Yusta, B., Tong, J. C. L., Broichhagen, J., Hodson, D. J., & Drucker, D. J. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.06.012 · Cited by 14
Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart
Krieger, J., Daniels, D., Lee, S. J., Mastitskaya, S., & Langhans, W. (2024) · Comprehensive physiology · doi:10.1002/cph4.7 · Cited by 15
“A particularly high expression of GLP-1Rs by neurons of the DMV is observed both in primate and rodent brains (Heppner et al. 2015; Jensen et al. 2018).”
Klausen, M. K., Kuzey, T., Pedersen, J. N., Justesen, S. K., Rasmussen, L. J. H., Knorr, U., Mason, G. F., Ekstrøm, C. T., Holst, J. J., Koob, G. F., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-086454 · Cited by 14
Oral Treatment of Obesity by GLP-1 and Its Analogs
Holler, N., Ruseska, I., Schachner-Nedherer, A.-L., Zimmer, A., & Petschacher, C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121596 · Cited by 13
GLP-1, GIP, and Glucagon Agonists for Obesity Treatment: A Hunger Perspective
d’Ávila, M., Hall, S., & Horváth, T. L. (2024) · Endocrinology · doi:10.1210/endocr/bqae128 · Cited by 14
Ruska, Y., Szilvásy‐Szabó, A., Kővári, D., Kádár, A., Mácsai, L., Sinkó, R., Hrabovszky, E., Gereben, B., & Fekete, C. (2021) · Brain Structure and Function · doi:10.1007/s00429-021-02380-y · Cited by 13
Higo, S., Ishii, H., & Ozawa, H. (2023) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.23-00024 · Cited by 13
Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice
McMorrow, H. E., Cohen, A. B., Lorch, C. M., Hayes, N. W., Fleps, S. W., Frydman, J. A., Xia, J. L., Samms, R. J., & Beutler, L. R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186652 · Cited by 12
“Emissions were collected through the patch cords”
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala
Duran, M., Willis, J. R., Dalvi, N., Fokakis, Z. N., VIRKUS, S., & Hardaway, J. A. (2025) · Endocrinology · doi:10.1210/endocr/bqaf019 · Cited by 13
Wang, Q., Zhang, X., Leng, H., Luan, X., Guo, F., Sun, X., Gao, S., Liu, X., Qin, H., & Xu, L. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102018 · Cited by 12
Ståhle, M. R., Hellberg, S., Virta, J., Liljenbäck, H., Metsälä, O., Li, X., Jauhiainen, M., Saukko, P. J., Ylä‐Herttuala, S., Nuutila, P., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00465.2020 · Cited by 13
Kay, E., Stulz, R., Becquart, C., Lovrić, J., Tängemo, C., Thomen, A., Baždarević, D., Najafinobar, N., Dahlén, A., Pielach, A., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020463 · Cited by 13
“Primary antibody incubations were performed with anti-GLP1R (Mab7F38 from Developmental Studies Hybridoma Bank, described in [24]), rabbit anti-early endosome-associated antigen 1 (EEA1) (Cell Signaling, Danvers, MA, USA) #C45B10) or rabbit anti-LAMP1 (Cell Signaling, Danvers, MA, USA) antibodies diluted in PBS + 2% B…”
MethodRepurposing GLP1 agonists for neurodegenerative diseases
Markaki, I., Winther, K., Catrina, S., & Svenningsson, P. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.007 · Cited by 14
Wang, X.-Y., Liu, Y., Cao, L.-X., Li, Y.-Z., Wan, P., & Qiu, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-34070-6 · Cited by 12
Topography of the GLP-1/GLP-1 receptor system in the spinal cord of male mice
Ruska, Y., Csibi, A., Dorogházi, B., Szilvásy‐Szabó, A., Mohácsik, P., Környei, Z., Dénes, Á., Kádár, A., Puskár, Z., Hrabovszky, E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65442-1 · Cited by 10
“We first examined the general distribution of Glp1r transcript with in situ hybridization, and the GLP-1R protein with immunohistological techniques, using a well-characterized, highly specific antibody 14,16,29 .”
MethodSonne, N., Roque, M., Zachariassen, L. F., Porsgaard, T., Pors, S. E., Cavalera, M., Jones, C., Osborn, O., Thorbek, D. D., Riis, M. L., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106121 · Cited by 9
“53 The physiological distribution pattern of hGLP1R is further supported by confirmed expression in several midbrain and brainstem regions, including the ARH, AP, and NTS. 5,54 A series of comparative studies were conducted to evaluate the in vivo functionality of the human GLP1R orthologue.”
Hviid, M. E. B., Christoffersen, L. A. N., Klausen, M. K., Brodersen, T., Pedersen, O. B., Ostrowski, S. R., Larsen, M. H., Kongstad, M., Jensen, M. E., Vilsbøll, T., et al. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70110 · Cited by 8
Liraglutide stimulates the β-catenin signaling cascade in mouse epididymal fat tissue
Gu, J., Shao, W., Liu, D., Feng, J. N., Pang, J., & Jin, T. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0026 · Cited by 8
GLP-1 Signalling as a Therapeutic Avenue in Parkinson’s Disease: A Comprehensive Review
Orozco, M. P., Rivadeneira, V. V., & León-Rojas, J. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412163 · Cited by 8
“Moderate to low levels of GLP-1R expression have been detected in the hippocampus (CA1 region), cerebral cortex, thalamus, caudate nucleus, globus pallidus, and brainstem nuclei [7,15].”
Metadata
- Authors
- Jensen, C. B., Pyke, C., Rasch, M. G., Dahl, A. B., Knudsen, L. B., & Secher, A.
- Affiliations
- Novo Nordisk (Denmark) (DK)
- Technical University of Denmark (DK)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2017-10-30
- Volume
- 159
- Issue
- 2
- Pages
- 665-675
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2766706007
- Cited by
- 145
- References
- 44
- Citations by year
- 2026: 22 · 2025: 19 · 2024: 14 · 2023: 23 · 2022: 17 · 2021: 21 · 2020: 17 · 2019: 9 · 2018: 3
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
- Funders
- Novo Nordisk
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- GLP-1 receptor, brain receptor distribution, monoclonal antibodies, mRNA-protein correlation, neuronal projections, hypothalamus, septal nuclei, brainstem, appetite regulation, GLP-1 receptor agonists, Allen Mouse Brain Atlas
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Animals, Antibodies, Brain, Male, Neurons, In Situ Hybridization, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.